SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-20-213729
Filing Date
2020-08-07
Accepted
2020-08-07 20:55:46
Documents
13

Document Format Files

Seq Description Document Type Size
1 424B4 d913691d424b4.htm 424B4 2095542
2 GRAPHIC g913691g04h75.jpg GRAPHIC 39512
3 GRAPHIC g913691g04k91.jpg GRAPHIC 95431
4 GRAPHIC g913691g11q85.jpg GRAPHIC 62953
5 GRAPHIC g913691g42o46.jpg GRAPHIC 127876
6 GRAPHIC g913691g56j74.jpg GRAPHIC 132300
7 GRAPHIC g913691g58e83.jpg GRAPHIC 129427
8 GRAPHIC g913691g60f61.jpg GRAPHIC 92362
9 GRAPHIC g913691g61q91.jpg GRAPHIC 125132
10 GRAPHIC g913691g79m46.jpg GRAPHIC 72977
11 GRAPHIC g913691g79p81.jpg GRAPHIC 49935
12 GRAPHIC g913691g95e80.jpg GRAPHIC 103915
13 GRAPHIC g913691g96a45.jpg GRAPHIC 124906
  Complete submission text file 0001193125-20-213729.txt   3685276
Mailing Address 245 MAIN STREET, 2ND FLOOR CAMBRIDGE MA 02142
Business Address 245 MAIN STREET, 2ND FLOOR CAMBRIDGE MA 02142 978-503-2124
Checkmate Pharmaceuticals, Inc. (Filer) CIK: 0001651431 (see all company filings)

IRS No.: 364813934 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-239932 | Film No.: 201086651
SIC: 2836 Biological Products, (No Diagnostic Substances)